Commentary

Business & Economics

New study shows fast food minimum wage law already a disaster

Is it too soon to declare California’s $20-an-hour minimum wage for fast food workers a disaster? After all, it became law only four months ago. How much harm could have been done in such a narrow time frame? Short answer? Quite a bit. The results of a just-released business survey ...
Commentary

FERC Is Considering Policies That Would Threaten Energy Reliability

Reliable and affordable energy is essential. Without it, many dire consequences will arise. Unreliable and unaffordable energy poses serious health risks – particularly for the elderly, increases the costs of food, disrupts business activity harming economic growth, and makes it more difficult for children to study. Maintaining an efficient energy ...
Commentary

Californians Will Have to Use Less Water Under State Board’s New Rules

It’s been said in different ways by a variety of people, but there’s more than just a grain of truth in it: If the federal bureaucracy or a socialist regime were ever put in charge of the Sahara Desert, there would eventually be a shortage of sand. This helps explain ...
Commentary

Vance Must Put America First on Healthcare

Ohio Sen. J.D. Vance has made quite a splash since arriving in Washington less than two years ago. He’s gone from the junior senator from Ohio and the 96th by seniority to the top of the Republican ticket as Donald Trump’s running mate. Vance has branded himself as an “America First” conservative. ...
Commentary

Kamala Harris’s healthcare record is rotten to the core

Democrats, including former President Barack Obama, have enthusiastically rallied around Vice President Kamala Harris as their presumptive presidential nominee. Voters will not be nearly as enthusiastic about her record on healthcare. Harris stands to President Joe Biden’s left on health policy. If elected, she would almost certainly drag the United States closer to a complete government ...
Commentary

Read the latest on the 340B Drug Pricing Program

Reforming 340B to Serve the Interests of Patients, Not Institutions

By Anthony M. DiGiorgio, DO, MHA and Wayne Winegarden, PhD Enacted by the US Congress in 1992 to help entities serving lower-income and uninsured patients stretch their resources, the 340B Drug Pricing Program mandated drug companies give large discounts to covered entities (CEs). Judging the program on its outcomes, not its intentions, ...
Commentary

Read about Kamala Harris' California crime record

Kamala Harris played a key role in California’s crime catastrophe — voters should be very worried

If what Kamala Harris helped do to California is an indication of what she’d do the nation, voters should be very, very worried. As state attorney general from 2011 to 2017, Harris refused to take a position on two ballot initiatives that have come to define modern California — but her office ...
Commentary

Read about Biden's plan to extend health insurance to DACA

Biden’s Healthcare Amnesty Solves Nothing — and at a Staggering Cost

The Biden administration recently finalized a rule extending subsidized health coverage to approximately 100,000 people without health insurance who entered the United States illegally. These folks are part of the Deferred Action for Childhood Arrivals, or DACA, program — a group sometimes known as “dreamers.” The new rule effectively rewrites ...
Commentary

Fauci Has Only Himself to Blame for His COVID Legacy

“We have seen complete fabrications become some people’s accepted reality,” Dr. Anthony Fauci laments in his new memoir “On Call: A Doctor’s Journey in Public Service.” Surely the good doctor means to speak about his ideological foes, who have long decried the heavy-handed response to COVID-19 that Dr. Fauci symbolizes. But today, ...
Commentary

We’re Closer Than Ever To Beating Alzheimer’s. Price Controls Could Change That.

Earlier this month, the U.S. Food and Drug Administration approved donanemab, a novel treatment for Alzheimer’s disease that Eli Lilly will sell under the brand name Kisunla. The drug targets amyloid, a type of protein that builds up in the brains of people with the disease. It was shown to slow the ...
Business & Economics

New study shows fast food minimum wage law already a disaster

Is it too soon to declare California’s $20-an-hour minimum wage for fast food workers a disaster? After all, it became law only four months ago. How much harm could have been done in such a narrow time frame? Short answer? Quite a bit. The results of a just-released business survey ...
Commentary

FERC Is Considering Policies That Would Threaten Energy Reliability

Reliable and affordable energy is essential. Without it, many dire consequences will arise. Unreliable and unaffordable energy poses serious health risks – particularly for the elderly, increases the costs of food, disrupts business activity harming economic growth, and makes it more difficult for children to study. Maintaining an efficient energy ...
Commentary

Californians Will Have to Use Less Water Under State Board’s New Rules

It’s been said in different ways by a variety of people, but there’s more than just a grain of truth in it: If the federal bureaucracy or a socialist regime were ever put in charge of the Sahara Desert, there would eventually be a shortage of sand. This helps explain ...
Commentary

Vance Must Put America First on Healthcare

Ohio Sen. J.D. Vance has made quite a splash since arriving in Washington less than two years ago. He’s gone from the junior senator from Ohio and the 96th by seniority to the top of the Republican ticket as Donald Trump’s running mate. Vance has branded himself as an “America First” conservative. ...
Commentary

Kamala Harris’s healthcare record is rotten to the core

Democrats, including former President Barack Obama, have enthusiastically rallied around Vice President Kamala Harris as their presumptive presidential nominee. Voters will not be nearly as enthusiastic about her record on healthcare. Harris stands to President Joe Biden’s left on health policy. If elected, she would almost certainly drag the United States closer to a complete government ...
Commentary

Read the latest on the 340B Drug Pricing Program

Reforming 340B to Serve the Interests of Patients, Not Institutions

By Anthony M. DiGiorgio, DO, MHA and Wayne Winegarden, PhD Enacted by the US Congress in 1992 to help entities serving lower-income and uninsured patients stretch their resources, the 340B Drug Pricing Program mandated drug companies give large discounts to covered entities (CEs). Judging the program on its outcomes, not its intentions, ...
Commentary

Read about Kamala Harris' California crime record

Kamala Harris played a key role in California’s crime catastrophe — voters should be very worried

If what Kamala Harris helped do to California is an indication of what she’d do the nation, voters should be very, very worried. As state attorney general from 2011 to 2017, Harris refused to take a position on two ballot initiatives that have come to define modern California — but her office ...
Commentary

Read about Biden's plan to extend health insurance to DACA

Biden’s Healthcare Amnesty Solves Nothing — and at a Staggering Cost

The Biden administration recently finalized a rule extending subsidized health coverage to approximately 100,000 people without health insurance who entered the United States illegally. These folks are part of the Deferred Action for Childhood Arrivals, or DACA, program — a group sometimes known as “dreamers.” The new rule effectively rewrites ...
Commentary

Fauci Has Only Himself to Blame for His COVID Legacy

“We have seen complete fabrications become some people’s accepted reality,” Dr. Anthony Fauci laments in his new memoir “On Call: A Doctor’s Journey in Public Service.” Surely the good doctor means to speak about his ideological foes, who have long decried the heavy-handed response to COVID-19 that Dr. Fauci symbolizes. But today, ...
Commentary

We’re Closer Than Ever To Beating Alzheimer’s. Price Controls Could Change That.

Earlier this month, the U.S. Food and Drug Administration approved donanemab, a novel treatment for Alzheimer’s disease that Eli Lilly will sell under the brand name Kisunla. The drug targets amyloid, a type of protein that builds up in the brains of people with the disease. It was shown to slow the ...
Scroll to Top